Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 May 15;332(Pt 1):21–34. doi: 10.1042/bj3320021

Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.

L S Ireland 1, D J Harrison 1, G E Neal 1, J D Hayes 1
PMCID: PMC1219447  PMID: 9576847

Abstract

The masking of charged amino or carboxy groups by N-phthalidylation and O-phthalidylation has been used to improve the absorption of many drugs, including ampicillin and 5-fluorouracil. Following absorption of such prodrugs, the phthalidyl group is hydrolysed to release 2-carboxybenzaldehyde (2-CBA) and the pharmaceutically active compound; in humans, 2-CBA is further metabolized to 2-hydroxymethylbenzoic acid by reduction of the aldehyde group. In the present work, the enzyme responsible for the reduction of 2-CBA in humans is identified as a homologue of rat aflatoxin B1-aldehyde reductase (rAFAR). This novel human aldo-keto reductase (AKR) has been cloned from a liver cDNA library, and together with the rat protein, establishes the AKR7 family of the AKR superfamily. Unlike its rat homologue, human AFAR (hAFAR) appears to be constitutively expressed in human liver, and is widely expressed in extrahepatic tissues. The deduced human and rat protein sequences share 78% identity and 87% similarity. Although the two AKR7 proteins are predicted to possess distinct secondary structural features which distinguish them from the prototypic AKR1 family of AKRs, the catalytic- and NADPH-binding residues appear to be conserved in both families. Certain of the predicted structural features of the AKR7 family members are shared with the AKR6 beta-subunits of voltage-gated K+-channels. In addition to reducing the dialdehydic form of aflatoxin B1-8,9-dihydrodiol, hAFAR shows high affinity for the gamma-aminobutyric acid metabolite succinic semialdehyde (SSA) which is structurally related to 2-CBA, suggesting that hAFAR could function as both a SSA reductase and a 2-CBA reductase in vivo. This hypothesis is supported in part by the finding that the major peak of 2-CBA reductase activity in human liver co-purifies with hAFAR protein.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. D., Dubnick M., Kerlavage A. R., Moreno R., Kelley J. M., Utterback T. R., Nagle J. W., Fields C., Venter J. C. Sequence identification of 2,375 human brain genes. Nature. 1992 Feb 13;355(6361):632–634. doi: 10.1038/355632a0. [DOI] [PubMed] [Google Scholar]
  2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J Mol Biol. 1990 Oct 5;215(3):403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  3. Bohren K. M., Bullock B., Wermuth B., Gabbay K. H. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem. 1989 Jun 5;264(16):9547–9551. [PubMed] [Google Scholar]
  4. Bohren K. M., Grimshaw C. E., Gabbay K. H. Catalytic effectiveness of human aldose reductase. Critical role of C-terminal domain. J Biol Chem. 1992 Oct 15;267(29):20965–20970. [PubMed] [Google Scholar]
  5. Bohren K. M., Page J. L., Shankar R., Henry S. P., Gabbay K. H. Expression of human aldose and aldehyde reductases. Site-directed mutagenesis of a critical lysine 262. J Biol Chem. 1991 Dec 15;266(35):24031–24037. [PubMed] [Google Scholar]
  6. Borhani D. W., Harter T. M., Petrash J. M. The crystal structure of the aldose reductase.NADPH binary complex. J Biol Chem. 1992 Dec 5;267(34):24841–24847. doi: 10.2210/pdb1abn/pdb. [DOI] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Chambliss K. L., Gibson K. M. Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum. Int J Biochem. 1992 Sep;24(9):1493–1499. doi: 10.1016/0020-711x(92)90077-e. [DOI] [PubMed] [Google Scholar]
  9. Chambliss K. L., Zhang Y. A., Rossier E., Vollmer B., Gibson K. M. Enzymatic and immunologic identification of succinic semialdehyde dehydrogenase in rat and human neural and nonneural tissues. J Neurochem. 1995 Aug;65(2):851–855. doi: 10.1046/j.1471-4159.1995.65020851.x. [DOI] [PubMed] [Google Scholar]
  10. Ciaccio P. J., Tew K. D. cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. Biochim Biophys Acta. 1994 Jun 28;1186(1-2):129–132. doi: 10.1016/0005-2728(94)90144-9. [DOI] [PubMed] [Google Scholar]
  11. Cromlish J. A., Yoshimoto C. K., Flynn T. G. Purification and characterization of four NADPH-dependent aldehyde reductases from pig brain. J Neurochem. 1985 May;44(5):1477–1484. doi: 10.1111/j.1471-4159.1985.tb08785.x. [DOI] [PubMed] [Google Scholar]
  12. Deyashiki Y., Ogasawara A., Nakayama T., Nakanishi M., Miyabe Y., Sato K., Hara A. Molecular cloning of two human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. Biochem J. 1994 Apr 15;299(Pt 2):545–552. doi: 10.1042/bj2990545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ellis E. M., Hayes J. D. Substrate specificity of an aflatoxin-metabolizing aldehyde reductase. Biochem J. 1995 Dec 1;312(Pt 2):535–541. doi: 10.1042/bj3120535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ellis E. M., Judah D. J., Neal G. E., Hayes J. D. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10350–10354. doi: 10.1073/pnas.90.21.10350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ellis E. M., Judah D. J., Neal G. E., O'Connor T., Hayes J. D. Regulation of carbonyl-reducing enzymes in rat liver by chemoprotectors. Cancer Res. 1996 Jun 15;56(12):2758–2766. [PubMed] [Google Scholar]
  16. England S. K., Uebele V. N., Shear H., Kodali J., Bennett P. B., Tamkun M. M. Characterization of a voltage-gated K+ channel beta subunit expressed in human heart. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6309–6313. doi: 10.1073/pnas.92.14.6309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grimshaw C. E. Aldose reductase: model for a new paradigm of enzymic perfection in detoxification catalysts. Biochemistry. 1992 Oct 27;31(42):10139–10145. doi: 10.1021/bi00157a001. [DOI] [PubMed] [Google Scholar]
  18. Hara A., Matsuura K., Tamada Y., Sato K., Miyabe Y., Deyashiki Y., Ishida N. Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochem J. 1996 Jan 15;313(Pt 2):373–376. doi: 10.1042/bj3130373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hara A., Taniguchi H., Nakayama T., Sawada H. Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J Biochem. 1990 Aug;108(2):250–254. doi: 10.1093/oxfordjournals.jbchem.a123189. [DOI] [PubMed] [Google Scholar]
  20. Harrison D. H., Bohren K. M., Ringe D., Petsko G. A., Gabbay K. H. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. Biochemistry. 1994 Mar 1;33(8):2011–2020. doi: 10.1021/bi00174a006. [DOI] [PubMed] [Google Scholar]
  21. Hayes J. D., Judah D. J., McLellan L. I., Kerr L. A., Peacock S. D., Neal G. E. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem J. 1991 Oct 15;279(Pt 2):385–398. doi: 10.1042/bj2790385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hayes J. D., Judah D. J., Neal G. E. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res. 1993 Sep 1;53(17):3887–3894. [PubMed] [Google Scholar]
  23. Hayes J. D., Kerr L. A., Cronshaw A. D. Evidence that glutathione S-transferases B1B1 and B2B2 are the products of separate genes and that their expression in human liver is subject to inter-individual variation. Molecular relationships between the B1 and B2 subunits and other Alpha class glutathione S-transferases. Biochem J. 1989 Dec 1;264(2):437–445. doi: 10.1042/bj2640437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hayes J. D., Pulford D. J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600. doi: 10.3109/10409239509083491. [DOI] [PubMed] [Google Scholar]
  25. Hoffman P. L., Wermuth B., von Wartburg J. P. Human brain aldehyde reductases: relationship to succinic semialdehyde reductase and aldose reductase. J Neurochem. 1980 Aug;35(2):354–366. doi: 10.1111/j.1471-4159.1980.tb06272.x. [DOI] [PubMed] [Google Scholar]
  26. Hoffmann G. F., Gibson K. M., Trefz F. K., Nyhan W. L., Bremer H. J., Rating D. Neurological manifestations of organic acid disorders. Eur J Pediatr. 1994;153(7 Suppl 1):S94–100. doi: 10.1007/BF02138786. [DOI] [PubMed] [Google Scholar]
  27. Hoog S. S., Pawlowski J. E., Alzari P. M., Penning T. M., Lewis M. Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2517–2521. doi: 10.1073/pnas.91.7.2517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Iwata N., Inazu N., Hara S., Yanase T., Kano S., Endo T., Kuriiwa F., Sato Y., Satoh T. Interindividual variability of carbonyl reductase levels in human livers. Biochem Pharmacol. 1993 Apr 22;45(8):1711–1714. doi: 10.1016/0006-2952(93)90313-l. [DOI] [PubMed] [Google Scholar]
  29. Jaffé G., Murphy J. E., Robinson O. P. A comparative study of talampicillin and ampicillin in general practice. Practitioner. 1976 Apr;216(1294):455–460. [PubMed] [Google Scholar]
  30. Jez J. M., Flynn T. G., Penning T. M. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol. 1997 Sep 15;54(6):639–647. doi: 10.1016/s0006-2952(97)84253-0. [DOI] [PubMed] [Google Scholar]
  31. Khanna M., Qin K. N., Wang R. W., Cheng K. C. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases. J Biol Chem. 1995 Aug 25;270(34):20162–20168. doi: 10.1074/jbc.270.34.20162. [DOI] [PubMed] [Google Scholar]
  32. Kondo K. H., Kai M. H., Setoguchi Y., Eggertsen G., Sjöblom P., Setoguchi T., Okuda K. I., Björkhem I. Cloning and expression of cDNA of human delta 4-3-oxosteroid 5 beta-reductase and substrate specificity of the expressed enzyme. Eur J Biochem. 1994 Jan 15;219(1-2):357–363. doi: 10.1111/j.1432-1033.1994.tb19947.x. [DOI] [PubMed] [Google Scholar]
  33. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  34. Leicher T., Roeper J., Weber K., Wang X., Pongs O. Structural and functional characterization of human potassium channel subunit beta 1 (KCNA1B). Neuropharmacology. 1996;35(7):787–795. doi: 10.1016/0028-3908(96)00133-5. [DOI] [PubMed] [Google Scholar]
  35. Li R., Bianchet M. A., Talalay P., Amzel L. M. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8846–8850. doi: 10.1073/pnas.92.19.8846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lieber C. S. Mechanisms of ethanol-drug-nutrition interactions. J Toxicol Clin Toxicol. 1994;32(6):631–681. doi: 10.3109/15563659409017974. [DOI] [PubMed] [Google Scholar]
  37. Maser E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem Pharmacol. 1995 Feb 14;49(4):421–440. doi: 10.1016/0006-2952(94)00330-o. [DOI] [PubMed] [Google Scholar]
  38. McCormack T., McCormack K. Shaker K+ channel beta subunits belong to an NAD(P)H-dependent oxidoreductase superfamily. Cell. 1994 Dec 30;79(7):1133–1135. doi: 10.1016/0092-8674(94)90004-3. [DOI] [PubMed] [Google Scholar]
  39. Molowa D. T., Shayne A. G., Guzelian P. S. Purification and characterization of chlordecone reductase from human liver. J Biol Chem. 1986 Sep 25;261(27):12624–12627. [PubMed] [Google Scholar]
  40. Morales M. J., Castellino R. C., Crews A. L., Rasmusson R. L., Strauss H. C. A novel beta subunit increases rate of inactivation of specific voltage-gated potassium channel alpha subunits. J Biol Chem. 1995 Mar 17;270(11):6272–6277. doi: 10.1074/jbc.270.11.6272. [DOI] [PubMed] [Google Scholar]
  41. Møss J., Bundgaard H. Prodrugs of peptides. 19. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by N-acyloxymethylation and other means. Acta Pharm Nord. 1992;4(4):301–308. [PubMed] [Google Scholar]
  42. Ohara H., Miyabe Y., Deyashiki Y., Matsuura K., Hara A. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem Pharmacol. 1995 Jul 17;50(2):221–227. doi: 10.1016/0006-2952(95)00124-i. [DOI] [PubMed] [Google Scholar]
  43. Pawlowski J. E., Penning T. M. Overexpression and mutagenesis of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. J Biol Chem. 1994 May 6;269(18):13502–13510. [PubMed] [Google Scholar]
  44. Penning T. M. Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chem Biol Interact. 1993 Oct;89(1):1–34. doi: 10.1016/0009-2797(93)03203-7. [DOI] [PubMed] [Google Scholar]
  45. Qin K. N., New M. I., Cheng K. C. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol. 1993 Dec;46(6):673–679. doi: 10.1016/0960-0760(93)90308-j. [DOI] [PubMed] [Google Scholar]
  46. Rettig J., Heinemann S. H., Wunder F., Lorra C., Parcej D. N., Dolly J. O., Pongs O. Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit. Nature. 1994 May 26;369(6478):289–294. doi: 10.1038/369289a0. [DOI] [PubMed] [Google Scholar]
  47. Rost B., Sander C. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol. 1993 Jul 20;232(2):584–599. doi: 10.1006/jmbi.1993.1413. [DOI] [PubMed] [Google Scholar]
  48. Sander C., Schneider R. Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins. 1991;9(1):56–68. doi: 10.1002/prot.340090107. [DOI] [PubMed] [Google Scholar]
  49. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Shiobara Y., Ogiso T. The effect of a carboxyl substituent on the metabolism in vitro of certain aromatic aldehydes. Xenobiotica. 1979 Mar;9(3):157–164. doi: 10.3109/00498257909038716. [DOI] [PubMed] [Google Scholar]
  51. Shiobara Y. The effect of carboxyl substituent on the metabolism of aromatic aldehydes. Xenobiotica. 1977 Aug;7(8):457–468. doi: 10.3109/00498257709035805. [DOI] [PubMed] [Google Scholar]
  52. Stolz A., Hammond L., Lou H., Takikawa H., Ronk M., Shively J. E. cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. J Biol Chem. 1993 May 15;268(14):10448–10457. [PubMed] [Google Scholar]
  53. Tillakaratne N. J., Medina-Kauwe L., Gibson K. M. gamma-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp Biochem Physiol A Physiol. 1995 Oct;112(2):247–263. doi: 10.1016/0300-9629(95)00099-2. [DOI] [PubMed] [Google Scholar]
  54. Tonda K., Hirata M. Purification and molecular properties of 2-carboxybenzaldehyde (CBA) reductase from phenobarbital-treated rat liver. Xenobiotica. 1992 Jun;22(6):691–699. doi: 10.3109/00498259209053131. [DOI] [PubMed] [Google Scholar]
  55. Tonda K., Kamata S., Hirata M. Metabolism of 1-phthalidyl 5-fluorouracil in rat liver and enzyme induction by phenobarbital. Xenobiotica. 1987 Jun;17(6):759–768. doi: 10.3109/00498258709043983. [DOI] [PubMed] [Google Scholar]
  56. Wang X., Sheikh S., Saigal D., Robinson L., Weiner H. Heterotetramers of human liver mitochondrial (class 2) aldehyde dehydrogenase expressed in Escherichia coli. A model to study the heterotetramers expected to be found in Oriental people. J Biol Chem. 1996 Dec 6;271(49):31172–31178. doi: 10.1074/jbc.271.49.31172. [DOI] [PubMed] [Google Scholar]
  57. Wermuth B., Münch J. D., von Wartburg J. P. Purification and properties of NADPH-dependent aldehyde reductase from human liver. J Biol Chem. 1977 Jun 10;252(11):3821–3828. [PubMed] [Google Scholar]
  58. Wermuth B., Platts K. L., Seidel A., Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochem Pharmacol. 1986 Apr 15;35(8):1277–1282. doi: 10.1016/0006-2952(86)90271-6. [DOI] [PubMed] [Google Scholar]
  59. Wilson D. K., Bohren K. M., Gabbay K. H., Quiocho F. A. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science. 1992 Jul 3;257(5066):81–84. doi: 10.1126/science.1621098. [DOI] [PubMed] [Google Scholar]
  60. Wilson D. K., Tarle I., Petrash J. M., Quiocho F. A. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9847–9851. doi: 10.1073/pnas.90.21.9847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Winters C. J., Molowa D. T., Guzelian P. S. Isolation and characterization of cloned cDNAs encoding human liver chlordecone reductase. Biochemistry. 1990 Jan 30;29(4):1080–1087. doi: 10.1021/bi00456a034. [DOI] [PubMed] [Google Scholar]
  62. Yoshihara S., Tatsumi K. Purification and characterization of hepatic aldehyde oxidase in male and female mice. Arch Biochem Biophys. 1997 Feb 1;338(1):29–34. doi: 10.1006/abbi.1996.9774. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES